MGNX
MACROGENICS INC
NASDAQ · Healthcare · Biotechnology · US
$3.33
+2.46%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.95x
- Price / sales
- 1.27x
- Price / cash flow
- -3.33x
Enterprise value
- Enterprise value
- $73.9M
- EV / sales
- 0.44x
- EV / EBITDA
- -0.90x
- EV / EBIT
- -1.81x
- Market cap
- $212.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026